Literature DB >> 7867658

Design of histamine H3-receptor agonists and antagonists.

W Schunack1, H Stark.   

Abstract

The development of highly potent and selective ligands for the characterization of histamine H3-receptors is reviewed. In the field of agonists stereoselectively methylated derivatives of the natural ligand are found to have the desired pharmacodynamic properties. Pharmacokinetic properties could be improved by forming bioreversible azomethine prodrugs of the primary amine with benzophenone derivatives. In the antagonist field a number of new leads belonging to different chemical classes are discovered. Potential compounds for drug development are identified. The radiolabelled probe [125I]iodoproxyfan shows high potency and selectivity in functional and binding studies. It is a useful compound for binding assays as well as for the detection and localization of histamine H3-receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7867658     DOI: 10.1007/BF03188918

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  14 in total

1.  Inhibition of guinea pig ileum contractions mediated by a class of histamine receptor resembling the H3 subtype.

Authors:  J P Trzeciakowski
Journal:  J Pharmacol Exp Ther       Date:  1987-12       Impact factor: 4.030

2.  [125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptors.

Authors:  X Ligneau; M Garbarg; M L Vizuete; J Diaz; K Purand; H Stark; W Schunack; J C Schwartz
Journal:  J Pharmacol Exp Ther       Date:  1994-10       Impact factor: 4.030

3.  Histamine secretion from rat enterochromaffinlike cells.

Authors:  C Prinz; M Kajimura; D R Scott; F Mercier; H F Helander; G Sachs
Journal:  Gastroenterology       Date:  1993-08       Impact factor: 22.682

4.  Characterization of histamine-H3 receptors controlling non-adrenergic non-cholinergic contractions of the guinea-pig isolated ileum.

Authors:  S J Taylor; G J Kilpatrick
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

5.  S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.

Authors:  M Garbarg; J M Arrang; A Rouleau; X Ligneau; M D Tuong; J C Schwartz; C R Ganellin
Journal:  J Pharmacol Exp Ther       Date:  1992-10       Impact factor: 4.030

6.  Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors.

Authors:  E Schlicker; K Fink; M Detzner; M Göthert
Journal:  J Neural Transm Gen Sect       Date:  1993

7.  Stereoselectivity of the histamine H3-presynaptic autoreceptor.

Authors:  J M Arrang; J C Schwartz; W Schunack
Journal:  Eur J Pharmacol       Date:  1985-10-29       Impact factor: 4.432

8.  Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor.

Authors:  J M Arrang; M Garbarg; J C Schwartz
Journal:  Nature       Date:  1983-04-28       Impact factor: 49.962

9.  Synthesis, absolute configuration, stereoselectivity, and receptor selectivity of (alpha R, beta S)-alpha,beta-dimethylhistamine, a novel high potent histamine H3 receptor agonist.

Authors:  R Lipp; J M Arrang; M Garbarg; P Luger; J C Schwartz; W Schunack
Journal:  J Med Chem       Date:  1992-11-13       Impact factor: 7.446

10.  Histamine H3 receptor-mediated inhibition of noradrenaline release in pig retina discs.

Authors:  E Schlicker; W Schunack; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.